The Benefit of Enhanced Day Care of Traditional Chinese Medicine: A Retrospective Study of Medical Records

Completed

• Conditions: Chemotherapy-Induced Change

• Registration Number: NCT04606121
• Lead Sponsor: Taipei City Hospital

Brief Summary

We collected medical records since June 2017 to November 2019., used pair-T test for questionnaire of CTCAE, BFT-I, WHOQOL to evaluate the benefit of enhanced day care of TCM for cancer patients.

Detailed Description

using TCM method as Complementary and Alternative Medicine is worldwide. we collected medical records that using TCM methods for adverse event from cancer therapies. we used CTCAE BFI-T and WHOQOF-BREF to evaluate the benefit.

Study Timeline

• Study Start: 2020-06-11
• Primary Completion: 2020-06-11
• Study Completion: 2020-06-11
• Status Verified: 2020-07
• Study First Submitted: 2020-10-23
• Study First Submitted QC: 2020-10-27
• Last Update Submitted: 2020-10-27
• Study First Posted: 2020-10-28
• Last Update Posted: 2020-10-28

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 401

Inclusion Criteria

• The medical records since June 2017 to December 2019 needed to meet the following criterial: (1)age>20 years old, (2)diagnosis meet ICD10:C00.0-C97 (3) needed to do Taiwan brief version of Common Terminology Criteria for Adverse Events Version4.0(Taiwan brief version scale of CTCAE), scale of the Taiwanese Version of the Brief Fatigue Inventory(BFI-T) and scale of the World Health Organization Quality of Life-BREF(WHOQOL-BREF), and those scales needed to be done pretest when patient came to the clinics and posttest when case end.

Exclusion Criteria

• The subjects will be excluded if they do not complete pretest and posttest of the following scales:(1) Taiwan brief version scale of CTCAE, (2) BFI-T scale (3) WHOQOL-BREF scale

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
scale of Taiwan brief version of Common Terminology Criteria for Adverse Events Version4.0(Taiwan brief version scale of CTCAE)	2020	for chemotherapy related adverse effects in Taiwan

Secondary Outcome Measures

Name	Time	Method
scale of the Taiwanese Version of the Brief Fatigue Inventory(BFI-T)	2020	evaluate the level of fatique
scale of the World Health Organization Quality of Life-BREF(WHOQOL-BREF)	2020	evaluate QOL

Trial Locations

Locations (1)

Taipei city hospital; 🇨🇳 Taipei, Taiwan